South Korea is one of the most active life science markets in the world. In 2019, USD 806.7m was invested in Korean private biotech companies that accounted for almost 4% of the total global biotech financing amount. The country currently offers hundreds of biotech and medtech assets to out-licence. We would like to thank our … Continue reading Korean Life Science Market Trend Analysis 2020
